BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
Clinical Trials Could Become More Difficult For Small Firms
Dec. 10, 2003
By
Nuala Moran
Cyclacel In-Licenses Cancer Compound From Sankyo Co.
Dec. 10, 2003
By
Nuala Moran
PPL On The Block; Dolly's Creator Fades Into History
Dec. 10, 2003
By
Nuala Moran
Clinical Trials Could Become More Difficult For Small Firms
Dec. 10, 2003
By
Nuala Moran
PPL On The Block; Dolly's Creator Fades Into History
Dec. 10, 2003
By
Nuala Moran
Cyclacel In-Licenses Cancer Compound From Sankyo Co.
Dec. 10, 2003
By
Nuala Moran
European Institutes Stepping In To Add Value To Technologies
Dec. 5, 2003
By
Nuala Moran
European Institutes Stepping In To Add Value To Technologies
Dec. 5, 2003
By
Nuala Moran
Education System Not Providing Skills Needed In Biotech Industry
Dec. 4, 2003
By
Nuala Moran
Education System Not Providing Skills Needed In Biotech Industry
Dec. 4, 2003
By
Nuala Moran
Previous
1
2
…
463
464
465
466
467
468
469
470
471
…
537
538
Next